Navigation Links
Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam 0.12%
Date:11/27/2012

ALLEGAN, Mich., Nov. 27, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq® Foam. Perrigo has manufactured the product and is preparing to commence commercial shipments on January 15, 2013, consistent with the date certain launch settlement. Cobrek was first to file, making the product eligible for 180 days of marketing exclusivity.

(Logo:  http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

Betamethasone valerate foam 0.12% is indicated for the relief of corticosteroid-responsive skin conditions of the scalp (scalp psoriasis). Brand annual sales were approximately $40 million.

Perrigo's Chairman, President and CEO Joseph C. Papa stated, "This is our sixth product approval using a foam dosage form, which requires specialized development and manufacturing capabilities. It is an example of the excellent partnership we have with Cobrek and we are committed to making quality healthcare more affordable for our customers and drive value for our shareholders."

From its beginnings as a packager of generic home remedies in 1887, Perrigo Company, based in Allegan, Michigan, has grown to become a leading global provider of quality, affordable healthcare products. The Company develops, manufactures and distributes over-the-counter ("OTC") and generic prescription ("Rx") pharmaceuticals, nutritional products and active pharmaceutical ingredients ("API") and is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. Perrigo's mission is to offer uncompromised "quality, affordable healthcare products", and it does so across a wide variety of product categories pri
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
2. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
3. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
4. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
5. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
6. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
7. Perrigo Company To Present At The William Blair Growth Stock Conference
8. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
9. Perrigo Company Announces Quarterly Dividend
10. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
11. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... York , July 11, 2014 ... Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative ... Share, Growth, Trends and Forecast, 2013-2019" the global endoscopy ... 2012 and is expected to grow at a CAGR ... estimated value of USD 36.9 billion in 2019. ...
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
(Date:7/10/2014)... 10, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year ended June 30, 2014 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... May 22, 2012  Today ZocDoc introduces ... instant online access to appointments with Greater Denver,s ... . At launch, this free service provides patients ... with participating primary care doctors, obstetrician-gynecologists, dermatologists and ...
... BOONTON, N.J., May 22, 2012  Unigene Laboratories, ... design, delivery, manufacture and development of peptide-based therapeutics ... studies in rats and dogs for its lead ... a potent anorexigenic peptide selectively targeting the amylin ...
Cached Medicine Technology:Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 3Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 2Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 3Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 5
(Date:7/13/2014)... 14, 2014 Recently, iFitDress.com, one of ... released its beautiful collection of brown evening dresses ... are now available at discounted prices, up to 50% ... of high quality; they are carefully made according to ... occasion gowns, iFitDress.com also offers pretty accessories: wedding shoes, ...
(Date:7/13/2014)... Dallas, TX (PRWEB) July 13, 2014 ... Roma vs. Real Madrid Tickets . For the fifth ... International Champions Cup will be held at American stadiums this ... world competing on American soil. The eight teams are split ... the group stage, the top two teams will compete to ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Chromatography ... biological components from various types of biological samples ... separate the sample mixture into two phase, namely ... the mobile phase run over the stationary phase, ... the components that provide the separation of mixture. ...
(Date:7/13/2014)... 13, 2014 The report “Micronutrient ... Iron), Form (Chelated & Non Chelated), Application Mode ... Global Trends and Forecast to 2018” defines and ... analysis and forecasting of the global value and ... driving and restraining factors for the global agriculture ...
(Date:7/13/2014)... York (PRWEB) July 13, 2014 A ... attention to the cancer risks associated with power morcellators ... tell their story to federal regulators, as they presented ... U.S. Food & Drug Administration (FDA) advisory panel meeting ... According to the Rochester Democrat and Chronicle, Dr. ...
Breaking Medicine News(10 mins):Health News:2014 Brown Evening Dresses Added To iFitDress.com 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 3Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4
... Dynavax Technologies,Corporation (Nasdaq: DVAX ) today reported ... ended September 30, 2007. The results do not,include ... As of September 30, 2007, Dynavax reported ... Symphony Dynamo, Inc. (SDI),totaling $68.7 million. This compares ...
... global clinical,research organization, is pleased to announce that ... JCAHPO annual continuing education,program. Diana who designed an ... in ophthalmic practice for several years,prior to joining ... will take place in New Orleans, Louisiana from ...
... have for the first time found stem cells in ... such cells might someday be used to help repair ... , Reporting November 1, 2007 in the journal ... Irving Shapiro, Ph.D., at Jefferson Medical College of Thomas ...
... Video Component Enables Users to Upload Video Confessions/ ... on newfaceofresearch.com for Peer-to-Peer Viewing, PHILADELPHIA and ... Thomson Corporation (NYSE: TOC ; TSX: TOC) ... research and,business communities, today announced the launch of ...
... Spectrum,Pharmaceuticals, Inc., (Nasdaq: SPPI ) announced today ... Thursday, November 1, 2007, at 2:00 p.m.,Pacific, at the ... in San Diego, California. Spectrum,s presentation will be held ... The live webcast of Spectrum,s presentation will be available ...
... Health Inc.,(TSX: DAX) (Nasdaq: DRAX ) announces that ... he will retire as the President and Chief,Executive Officer ... Barkin joined the senior management of DRAXIS in 1992. ... guiding the Company through,a period of significant growth from ...
Cached Medicine News:Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 2Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 3Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 4Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 5Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 6Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 7Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 8Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 9Health News:Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting 2Health News:Jefferson researchers find stem cells in degenerating spinal discs, potential for repair 2Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:Spectrum Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 3Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 4
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: